A phase III clinical trial to test the effectiveness of the HIV microbicide Ushercell was recently stopped because interim analysis indicated that the rate of infection with HIV in women using the microbicide was higher than the rate of infection in those using the placebo. Ushercell, which was being developed by the nonprofit reproductive health organization CONRAD, is a cellulose sulfate comp...